MedPath
HSA Product

PEDITRACE CONCENTRATE FOR PARENTERAL INFUSION

Product approved by Health Sciences Authority (SG)

Basic Information

PEDITRACE CONCENTRATE FOR PARENTERAL INFUSION

INJECTION

Regulatory Information

SIN08899P

September 4, 1996

Prescription Only

Therapeutic

INTRAVENOUS

August 10, 2023

June 3, 2025

XA12CX

Company Information

FRESENIUS KABI (SINGAPORE) PTE LTD

FRESENIUS KABI (SINGAPORE) PTE LTD

Active Ingredients

POTASSIUM IODIDE

Strength: 1.31 mcg/ml

SODIUM FLUORIDE

Strength: 126 mcg/ml

COPPER CHLORIDE DIHYDRATE

Strength: 53.7 mcg/ml

ZINC CHLORIDE

Strength: 521 mcg/ml

SODIUM SELENITE ANHYDROUS

Strength: 4.38 mcg/ml

© Copyright 2025. All Rights Reserved by MedPath